References
- European Medicines Agency. Guideline on similar biological medicinal products [Internet] [cited 2018 Apr 24]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_gui deline/2009/09/WC500003517.pdf. 2005.
- World Health Organization. Guidelines on evaluation of similar biotherapeutic products (SBPs) [Internet]. 2009 [cited 2018 Apr 24]. http://www.who.int/biologicals/areas/biological_therapeutics/BIOTHERAPEUTICS_FOR_WEB_22APRIL2010.pdf.
- Macdonald JC, Hartman H, Jacobs IA. Regulatory considerations in oncologic biosimilar drug development. mAbs. 2015;7(4):653–661.
- European Medicines Agency. Refusal assessment report for Alpheon [Internet] [cited 2017 Aug 24]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/000585/WC500070792.pdf.
- European Medicines Agency. Withdrawal Assessment Report. Insulin human [Internet] [cited 2018 Apr 24]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Application_withdrawal_assessment_report/2013/02/WC500138884.pdf.
- European Medicines Agency. Assessment report. Biferonex [Internet] [cited 2018 Apr 24]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Application_withdrawal_assessment_report/2010/01/WC500061394.pdf.
- European Medicines Agency. Assessment report. Solumrv [Internet] [cited 2018 Apr 24]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/003858/WC500201969.pdf.
- European Medicines Agency. Assessment report. Omnitrope [Internet] [cited 2018 Apr 24]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000607/WC500043692.pdf.
- European Medicines Agency. Assessment report. Valtropin [Internet] [cited 2018 Apr 24]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000602/WC500047158.pdf.
- European Medicines Agency. Assessment report. Binocrit [Internet] [cited 2018 Apr 24]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000725/WC500053615.pdf.
- European Medicines Agency. Assessment report. Retacrit [Internet] [cited 2018 Apr 24]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000725/WC500053615.pdf.
- European Medicines Agency. Assessment report. Abasria [Internet] [cited 2018 Apr 24]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002835/WC500175383.pdf.
- European Medicines Agency. Assessment report. Ovaleap [Internet] [cited 2018 Apr 24]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002608/WC500152908.pdf.
- European Medicines Agency. Assessment report. Bemfola [Internet] [cited 2018 Apr 24]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002615/WC500166820.pdf.
- European Medicines Agency. Assessment report. Inflectra [Internet] [cited 2018 Apr 24]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002778/WC500151490.pdf.
- Steelman SL, Pohley FM. Assay of FSH based on the augmentation with hCG. Endocrinology. 1953;53:604–616.
- De Leeuw R, Mulders J, Voortman G, et al. Structure–function relationship of recombinant follicle stimulating hormone (Puregon). Mol Hum Reprod. 1996;2:361–369.
- Orvieto R, Seifer DB. Biosimilar FSH preparations are they identical twins or just siblings? Reprod Biol Endocrinol. 2016;14(1):32–43.
- Ulloa-Aguirre A, Midgley AR Jr, Beitins IZ, Padmanabhan V. Follicle-stimulating isohormones: characterization and physiological relevance. Endocr Rev. 1995;16:765–787.
- European Medicines Agency. Guideline on non-clinical and clinical development of similar biological medicinal products containing recombinant human insulin and insulin analogues (EMEA/CHMP/BMWP/32775/2005_Rev. 1) [Internet] [cited 2018 Apr 24]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2015/03/WC500184161.pdf.
- European Medicines Agency. Guideline on Immunogenicity assessment of therapeutic proteins [Internet] [cited 2018 Apr 24]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2017/06/WC500228861.pdf.